Recall Radar
All recallsMedicine & devices

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

cGMP deviations.

Class II Medicine & devices FDA May 6, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Wells Pharma of Houston LLC — Houston, TX
Severity
Class II — moderate
Reported
May 6, 2026
Quantity
50 syringes
Recall number
D-0508-2026
Status
Ongoing
Source
FDA

Where it went

U.S. Nationwide.

Other medicine & devices recalls

See every current recall on the live dashboard →